YAN LIU to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications YAN LIU has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.180
-
Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality. Clin Gastroenterol Hepatol. 2019 09; 17(10):2117-2125.e3.
Score: 0.092
-
The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans. Am J Gastroenterol. 2018 09; 113(9):1310.
Score: 0.088